Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Anti-PR1/HLA-A2 Antibody (8F4, A TCR-Mimic) Mediates Specific Lysis of AML Stem Cells but Not Normal Hematopoietic Stem Cells.

Anna Sergeeva, Ph.D., Gheath Alatrash, D.O., Ph.D., Karen Clise-Dwyer, Ph.D., Kathryn E Quintanilla, Sijie Lu, Ph.D., Qing Ma, Ph.D., Dan Li, Ph.D., Yang Wang, M. James You, M.D., Ph.D., Jeffrey J. Molldrem, M.D.

Blood (2009) 114 (22): 15.

https://doi.org/10.1182/blood.V114.22.15.15

Published: 2009

Journal Articles

T-Cell Immunity to Two HLA-A2-Restricted Self-Determinants of Cyclin E May Contribute to Remission After Stem Cell Transplantation.

Hong He, M.D., Ph.D., Ken Ishiyama, M.D., Ph.D., Gheath Alatrash, D.O., Ph.D., Yukio Kondo, M.D., Ph.D., Sijie Lu, Ph.D., Jeffrey J. Molldrem, M.D.

Blood (2009) 114 (22): 686.

https://doi.org/10.1182/blood.V114.22.686.686

Published: 2009

Journal Articles

Aberrant Subcellular Localization of Azurophil Granule Proteins in Myeloid Leukemia Favors Peptide Antigen Presentation on MHC-I and Susceptibility to Killing by Cytotoxic T Lymphocytes.

Gheath Alatrash, DO, PhD, Yoko Ono, Ph.D., Sijie Lu, Ph.D., Anna Sergeeva, Ph.D., Changqing Wang, M.D., Eric Wieder, Ph.D., Jeffrey J. Molldrem, M.D.

Blood (2007) 110 (11): 4900.

https://doi.org/10.1182/blood.V110.11.4900.4900

Published: 2007

Journal Articles

High Avidity Cyclin E1-Derived Peptide-Specific CTL Kill Lymphoid Leukemia Cells and Cross-Recognize a Homologous Cyclin E2-Derived Peptide.

Yukio Kondo, M.D., Eric Wieder, Ph.D., Sijie Lu, Ph.D., Jeffrey Molldrem, M.D.

Blood (2004) 104 (11): 4498.

https://doi.org/10.1182/blood.V104.11.4498.4498

Published: 2004

Journal Articles

Antigen Cross-Presentation Allows the PR1 Leukemia-Associated Antigen To Be Processed from Both Proteinase 3 and Neutrophil Elastase to Prime T Cells.

Yoko Ono, M.D., Yukio Kondo, M.D., Anna Sergeeva, Ph.D., Olanike Akande, Pariya Sukhmalchandra, Sijie Lu, Ph.D., Eric Wieder, Ph.D., Jeffrey J. Molldrem, M.D.

Blood (2004) 104 (11): 3245.

https://doi.org/10.1182/blood.V104.11.3245.3245

Published: 2004

NARROW

Anti-PR1/HLA-A2 Antibody (8F4, A TCR-Mimic) Mediates Specific Lysis of AML Stem Cells but Not Normal Hematopoietic Stem Cells.

T-Cell Immunity to Two HLA-A2-Restricted Self-Determinants of Cyclin E May Contribute to Remission After Stem Cell Transplantation.

Aberrant Subcellular Localization of Azurophil Granule Proteins in Myeloid Leukemia Favors Peptide Antigen Presentation on MHC-I and Susceptibility to Killing by Cytotoxic T Lymphocytes.

High Avidity Cyclin E1-Derived Peptide-Specific CTL Kill Lymphoid Leukemia Cells and Cross-Recognize a Homologous Cyclin E2-Derived Peptide.

Antigen Cross-Presentation Allows the PR1 Leukemia-Associated Antigen To Be Processed from Both Proteinase 3 and Neutrophil Elastase to Prime T Cells.

Email alerts

ASH Publications

American Society of Hematology

Anti-PR1/HLA-A2 Antibody (8F4, A TCR-Mimic) Mediates Specific Lysis of AML Stem Cells but Not Normal Hematopoietic Stem Cells.

T-Cell Immunity to Two HLA-A2-Restricted Self-Determinants of Cyclin E May Contribute to Remission After Stem Cell Transplantation.

Aberrant Subcellular Localization of Azurophil Granule Proteins in Myeloid Leukemia Favors Peptide Antigen Presentation on MHC-I and Susceptibility to Killing by Cytotoxic T Lymphocytes.

High Avidity Cyclin E1-Derived Peptide-Specific CTL Kill Lymphoid Leukemia Cells and Cross-Recognize a Homologous Cyclin E2-Derived Peptide.

Antigen Cross-Presentation Allows the PR1 Leukemia-Associated Antigen To Be Processed from Both Proteinase 3 and Neutrophil Elastase to Prime T Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only